For patients with a post-fall lumbar disc protrusion and an annular tear who have been told fusion is the next step, a staged non-surgical approach—anchored in biologic disc repair—can produce meaningful, measurable pain reduction without hardware. The illustrative case below tracks that process over 18 months, with VAS pain falling from 78 mm to 22 mm.
Note: The following is a composite illustrative scenario drawn from patterns the Valor team encounters regularly in clinical evaluation. No real patient is identified. Details have been constructed to be representative, not to depict a specific individual.
Illustrative Case at a Glance
| Field | Detail |
|---|---|
| Patient archetype | 64-year-old retired elementary school teacher, post-fall lumbar injury |
| Diagnosis | L4-L5 disc protrusion with annular tear; preexisting facet osteoarthritis |
| Mechanism | Fall down four wooden porch steps onto the lower back |
| Surgical recommendation received | L4-L5 instrumented fusion (declined) |
| Approach used | Staged conservative care, targeted decompression, intra-annular fibrin injection |
| Primary outcomes | VAS 78 → 22 mm; ODI 52% → 14%; opioid-free at 16 weeks |
| Follow-up window | 18 months |
This illustrative scenario is part of the Valor team’s broader work on spinal fusion alternatives and reflects the staged decision framework applied to post-fall lumbar injuries in adults over 60. For the full conservative-first roadmap, see how to avoid spinal fusion surgery.
What Did the Clinical Picture Look Like at Baseline?
The patient in this illustrative scenario is a retired public school teacher who lives independently with her husband. She fell down four porch steps in early winter, landing on her sacrum and lower lumbar spine. She walked away from the fall, applied ice, and expected the pain to resolve. Six weeks later, pain had migrated into her right buttock and posterior thigh, and she had begun limiting her morning walks, garden work, and trips to see her grandchildren.
Her primary care physician ordered lumbar MRI imaging. The study showed a focal L4-L5 disc protrusion contacting the right traversing L5 nerve root, an annular fissure at the same level, multilevel facet hypertrophy consistent with age-related osteoarthritis, and mild central canal narrowing. There was no fracture, no instability on flexion-extension radiographs, and no progressive neurological deficit.
Baseline measurements at intake:
- Visual Analog Scale (VAS) pain score: 78 mm out of 100
- Oswestry Disability Index (ODI): 52% (severe disability range)
- Standing tolerance: under 10 minutes before forced sitting
- Walking tolerance: 5–7 minutes before right-leg radiation forced rest
- Sleep: waking 3–4 times per night with positional pain
- Medication: scheduled acetaminophen, intermittent oxycodone, gabapentin 300 mg three times daily
A regional spine surgeon reviewed the imaging and recommended L4-L5 instrumented fusion, citing her age, the fall mechanism, the disc protrusion, and the underlying osteoarthritis. She sought a second opinion specifically because she did not want fusion. Her concerns align with what published literature confirms: back surgery carries roughly a 40% failure rate (Failed Back Surgery Syndrome), and average recovery from spinal fusion extends 3–6 months or longer. Individual outcomes vary. She wanted to know whether her injury truly required hardware.
How Was the Non-Surgical Plan Structured?
The clinical reading of this case was that the fall had aggravated a pre-existing degenerative segment but had not produced the kind of structural damage that mandates fusion. There was no instability, no progressive weakness, no cauda equina signs, and no failed prior conservative trial. The Valor team built a staged plan with four objectives, in order: calm the inflammatory phase, restore neural mobility, repair the annular tear biologically, and rebuild capacity in the surrounding musculature.
The plan was deliberately sequenced rather than simultaneous. Stacking every modality at once obscures which intervention is actually moving the needle and depletes the patient’s time and patience. Staging also lets the body respond before the next input is introduced.
Stage 1 — Inflammatory control and neural desensitization (weeks 0–6). Activity modification, lumbar-specific physical therapy focused on directional preference and nerve glides, mechanical traction trials, and a single transforaminal epidural steroid injection at right L4-L5. The injection was used as a diagnostic-therapeutic test, not as a long-term solution. An AAFP systematic review classifies epidural steroids as not effective for chronic low back pain in isolation, but they remain useful for acute radicular flares to enable rehabilitation to proceed.
Stage 2 — Targeted decompression and motor control (weeks 6–14). Non-surgical spinal decompression at L4-L5 (20 sessions), continued physical therapy with a shift to hip and core endurance work, and structured daily walking. Published cohort data show spinal decompression produces sustained improvement in approximately 36.8% of patients at 6 months—a reasonable adjunct given the favorable response to manual traction in Stage 1. Individual outcomes vary.
Stage 3 — Biologic disc repair (week 16). Intra-annular fibrin injection at L4-L5 to address the annular fissure directly. The fibrin sealant used is FDA-approved as a sealant. Published cohort data on this approach show VAS scores moving from 72.4 mm at baseline to 33.0 mm at 104 weeks, with 70% patient satisfaction at 2-plus year follow-up and 80% positive outcomes among patients who had previously undergone back surgery. Individual outcomes vary. The fibrin procedure addresses the structural defect rather than masking the symptom.
Stage 4 — Capacity rebuilding (weeks 16–72). Progressive loading through supervised physical therapy, aquatic exercise, and an independent home program targeting lumbar stability, hip abductor strength, and walking endurance. Functional goals were set collaboratively: return to 30-minute morning walks, active gardening, and unassisted grandchild care.
Clinical Note
What the Valor team sees repeatedly in patients like this is a binary being forced on them that doesn’t have to exist. A fall, a protrusion, some osteoarthritis, and a fusion recommendation—and the patient is left feeling like the decision has already been made for her. It hasn’t. A staged conservative approach with biologic disc repair gives the disc an opportunity to heal structurally, not just symptomatically. The goal isn’t to avoid surgery at any cost. The goal is to make sure surgery is truly the only remaining option before recommending it—and in cases like this one, it often isn’t.
What Did the Outcomes Look Like at 18 Months?
Tracked outcomes at key intervals in this illustrative scenario are summarized below. These figures are representative of the staged approach described and are not a guarantee of individual results.
| Measure | Baseline | Week 16 | Month 12 | Month 18 |
|---|---|---|---|---|
| VAS pain score (mm) | 78 | 48 | 31 | 22 |
| ODI (%) | 52 | 36 | 20 | 14 |
| Standing tolerance | <10 min | 20 min | 45 min | 60+ min |
| Walking tolerance | 5–7 min | 15 min | 25 min | 30+ min |
| Opioid use | Intermittent | Discontinued | None | None |
| Gabapentin | 300 mg TID | Tapered | Discontinued | None |
At 18 months, the patient in this scenario had returned to morning walks of 30 minutes or more, active garden work, and unassisted grandchild care—the three functional goals she identified at intake. No surgical intervention was performed. A clinical evaluation is the only way to know whether outcomes like these are realistic for any individual patient.
Why Does a Staged Approach Matter for Post-Fall Disc Injuries?
A staged approach matters because post-fall lumbar disc injuries in adults over 60 typically involve more than one pathology at once. Addressing only one layer—say, inflammation—while ignoring the annular tear leaves the structural problem intact. Conversely, proceeding directly to an invasive repair before calming the acute inflammatory phase can obscure the true extent of residual pathology.
Staging also produces cleaner data. When each intervention is introduced in sequence, the clinical team can track which step moved the needle and calibrate accordingly. That clarity protects the patient from unnecessary escalation and from stalling on a step that isn’t working.
For more on the decision framework behind spinal fusion alternatives, see Spinal Fusion Alternatives: Treatment Options & Decision FAQ and Am I a Candidate for Spinal Fusion Alternatives?
Who Is a Candidate for This Kind of Approach?
A clinical evaluation is the only way to know for certain. The approach described in this scenario—staged conservative care followed by intra-annular fibrin injection—is designed for patients whose disc pathology involves an annular tear or disc protrusion, who have not yet exhausted conservative options, and who do not present with conditions requiring emergent surgical intervention (such as progressive neurological deficit or cauda equina syndrome).
The Valor team evaluates each patient’s MRI findings, symptom timeline, prior treatment history, and functional goals before recommending any treatment path. Patients who have already tried physical therapy, injections, or medications without lasting relief are among those most commonly evaluated for the fibrin procedure. See 11 Common Spine Treatment Mistakes Patients Make Before Surgery for a practical overview of what to avoid before escalating care.
Frequently Asked Questions
Is a post-fall disc protrusion always a surgical case?
No. A fall can aggravate an existing disc segment without producing the structural instability or neurological compromise that surgery requires. A clinical evaluation—including review of imaging and neurological status—is the only way to determine whether surgery is truly indicated.
What is intra-annular fibrin injection and how does it work for disc tears?
Intra-annular fibrin injection is a minimally invasive procedure in which an FDA-approved fibrin sealant is delivered under imaging guidance through a thin catheter directly into the annular tear. The fibrin sealant is intended to seal the tear and support the disc’s natural healing process. The procedure takes under one hour, requires no incisions, and is performed under local or light sedation. The fibrin sealant is FDA-approved as a sealant; specific clinical applications and individual outcomes vary by patient.
How long does recovery take after the fibrin procedure?
Most patients return to light activity within days. Functional improvement is typically progressive over weeks to months as the disc heals and physical capacity is rebuilt through rehabilitation. Among the most-tracked outcomes in published cohort data, VAS pain scores moved from 72.4 mm at baseline to 33.0 mm at 104 weeks. Individual outcomes vary.
What if I’ve already been told I need spinal fusion?
A surgical recommendation is not a mandate. Patients who have received a fusion recommendation and are not ready to proceed have the right to seek a second opinion and to explore whether non-surgical options have been fully exhausted. A clinical evaluation determines whether the fibrin procedure or another staged approach is appropriate. See What Is Spinal Fusion? Procedure, Risks, and Non-Surgical Alternatives for context on what fusion involves and what alternatives exist.
Does age affect candidacy for the fibrin procedure?
Age alone is not a disqualifying factor. Candidacy depends on the specific disc pathology, overall health status, and clinical findings—not on age as a standalone variable. A clinical evaluation is the only way to determine whether the procedure is appropriate for a given patient.
How does the Valor team decide between a staged conservative approach and going directly to the fibrin procedure?
The decision depends on the severity and acuity of the presentation. In post-fall cases with an active inflammatory component and no prior conservative trial, staging typically produces better outcomes than moving directly to intervention. In cases where conservative care has already been exhausted, the Valor team evaluates whether the annular tear is the primary driver and whether the patient meets criteria for the fibrin procedure as a next step. A clinical evaluation establishes which path applies.
This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. It is not a substitute for evaluation by a qualified physician. Treatment decisions depend on your individual medical history and clinical findings. Schedule a consultation to discuss whether the procedure is right for you.
